GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 25 filers reported holding GAIN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 2.41 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,264 | +19.0% | 1,300 | +62.5% | 0.00% | – |
| Q2 2023 | $3,584 | -7.1% | 800 | 0.0% | 0.00% | – |
| Q1 2023 | $3,856 | +54.0% | 800 | 0.0% | 0.00% | – |
| Q4 2022 | $2,504 | -37.4% | 800 | -24.0% | 0.00% | – |
| Q3 2022 | $4,000 | +33.3% | 1,052 | +31.5% | 0.00% | – |
| Q2 2022 | $3,000 | 0.0% | 800 | -0.4% | 0.00% | – |
| Q1 2022 | $3,000 | -25.0% | 803 | +0.4% | 0.00% | – |
| Q4 2021 | $4,000 | -33.3% | 800 | 0.0% | 0.00% | – |
| Q3 2021 | $6,000 | -25.0% | 800 | 0.0% | 0.00% | – |
| Q2 2021 | $8,000 | -33.3% | 800 | 0.0% | 0.00% | – |
| Q1 2021 | $12,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|